Assessment of neuroAIDS in the international setting

Journal of Neuroimmune Pharmacology

Volumn 2, Issue 1, 2007, Pages 105-111

  Robertson, Kevin R ^a   Hall, Colin D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; HAART; HIV; NeuroAIDS; Neurological; Neuropsychological; Resource limited

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; ANIMAL; DEVELOPED COUNTRY; DEVELOPING COUNTRY; HUMAN; INTERNATIONAL COOPERATION; REVIEW; SOUTH AND CENTRAL AMERICA; SOUTHEAST ASIA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; AIDS DEMENTIA COMPLEX; ANIMALS; ASIA, SOUTHEASTERN; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; INTERNATIONALITY; LATIN AMERICA;

EID: 33846822051     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-006-9052-0     Document Type: Review

References (38)

1. AAN (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. In: Neurology, pp 778-785
2. Belec L, Martin PM, Vohito MD, Gresenguet G, Tabo A, Georges AJ (1989) Low prevalence of neuro-psychiatric clinical manifestations in central African patients with acquired immune deficiency syndrome. Trans R Soc Trop Med Hyg 83:844-846
3. Brew BJ (2003) The peripheral nerve complications of human immunodeficiency virus (HIV) infection. Muscle Nerve 28:542-552
4. Clifford D, Evans S (2006) Ethiopian NeuroAIDS Assessment. In: Assessment of NeuroAIDS in Africa. Arusha, Tanzania Deutsch R, Ellis RJ, McCutchan JA, Marcotte TD, Letendre S, Grant I (2001) AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy. AIDS 15:1898-1899
5. Elder GA, Sever JL (1988) AIDS and neurological disorders: an overview. Ann Neurol 23(Suppl):S4-S6
6. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM, Hahn BH (1999) Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397:436-441
7. Gendelman HE, Zheng J, Coulter CL, Ghorpade A, Che M, Thylin M, Rubocki R, Persidsky Y, Hahn F, Reinhard J Jr, Swindells S (1998) Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J Infect Dis 178:1000-1007
8. Grant I (2006) Studies of Neurologic Complications of HIV in China, India and Brazil. In: Assessment of Resources and Opportunities for NeuroAIDS research in Nigeria/West Africa and Central Africa. Abuja, Nigeria
9. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317-331
10. Howlett WP, Nkya WM, Mmuni KA, Missalek WR (1989) Neurological disorders in AIDS and HIV disease in the northern zone of Tanzania. AIDS 3:289-296
11. Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, Nakiyingi J, Rutebemberwa A, Morgan D, Weber J, Gilks C, Whitworth J (2002) Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 185:1244-1250
12. Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, Woodcock SA, Gueye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, Ndoye I, Essex ME, Mboup S (1999) Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 179:68-73
13. Laeyendecker O, Li X, Arroyo R, McCutchan F, Gray R, Wawer M et al. (2006) The effect of HIV subtype on rapid disease progression in Rakai, Uganda. In: CROI. Denver
14. Langford D, Marquie-Beck J, de Almeida S, Lazzaretto D, Letendre S, Grant I, McCutchan JA, Masliah E, Ellis RJ (2006) Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. J Neurovirol 12:100-107
15. Letendre SL, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, Heaton RK, Grant I, Ellis RJ (2004) Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol 56:416-423
16. Maj M, Satz P, Janssen R, Zaudig M, Starace F, D'Elia L, Sughondhabirom B, Mussa M, Naber D, Ndetei D, et al. (1994) WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry 51:51-61
17. Marcotte TD, Wolfson T, Rosenthal TJ, Heaton RK, Gonzalez R, Ellis RJ, Grant I (2004) A multimodal assessment of driving performance in HIV infection. Neurology 63:1417-1422
18. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N (2003) Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirology 9:205-221
19. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP, et al. (1993) Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43:2245-2252
20. Nakasujja N, Wong M, Robertson K, McArthur J, Sacktor N (2004) HIV-associated neurological complications among HIV-seropositive individuals in Uganda. Neurology 62:A444
21. Navia BA, Jordan BD, Price RW (1986a) The AIDS dementia complex: I. Clinical features. Ann Neurol 19:517-524
22. Navia BA, Cho ES, Petito CK, Price RW (1986b) The AIDS dementia complex: II. Neuropathology. Ann Neurol 19:525-535
23. Robertson KR, Hall CD (1992) Human immunodeficiency virus-related cognitive impairment and the acquired immunodeficiency syndrome dementia complex. Semin Neurol 12:18-27
24. Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, Hall CD (2004) Highly active antiretroviral therapy improves neurocognitive functioning. AIDS 36:562-566
25. Sacktor N (2006) Assessment of HIV dementia in Uganda: results from the academic alliance cohort. In: Assessment of NeuroAIDS in Africa. Arusha, Tanzania
26. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirology 8:136-142
27. Schifitto G, Kieburtz K, McDermott MP, McArthur J, Marder K, Sacktor N, Palumbo D, Selnes O, Stern Y, Epstein L, Albert S (2001) Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes. Neurology 56:415-418
28. Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez R, Brown GG, Ellis RJ, Letendre S, Videen JS, McCutchan JA, Patterson TL, Grant I (2005) Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirology 11:356-364
29. Shiramizu B, Nidhinandana S, Sithinamsuwan P, Sataporn T, Apateerapong W, Ratto-Kim S, Chitpatima S, Robertson K, Troelstrup D, Anderson E, Shikuma C, Valcour V (2006 (February)) HIV DNA Correlates with HIV-1-Associated Dementia in Patients in Bangkok, Thailand. In: 13th Conference of Retrovirology and Opportunistic Infections. Denver, CO, USA
30. Simpson DM, Haidich AB, Schifitto G, Yiannoutsos CT, Geraci AP, McArthur JC, Katzenstein DA (2002) Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS 16:407-412
31. Tozzi V, Balestra P, Galgani S, Murri R, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Costa M, Sampaolesi A, Fantoni M, Noto P, Ippolito G, Wu AW (2003) Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retroviruses 19:643-652
32. UNAIDS (2003) Global summary of the HIV/AIDS epidemic. In: UNAIDS, Geneva, Switzerland
33. Valcour V, Nidhinandana S, Sithinamsuwan P, Thitivichianlert S, Apateerapong W, Ratto-Kim S, Kim J, Shiramizu B, Chitpatima S, Sukwit S, Chuenchitra T, Watt G, Robertson K, Paul R, Shikuma C (2005) Neuropsychological testing abnormalities among HIV patients in Bangkok, Thailand. In: Conference on HIV infection and the central nervous system: developed and resource-limited settings. Frascati, Italy
34. Van Rie A, Mupuala A, Dow Nosse N, Zephyrin I, Kilese N (2006) HIV/AIDS and neurodevelopment in sub-Saharan Africa. In: Assessment of NeuroAIDS in Africa. Arusha, Tanzania
35. Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, Fawzi W, Hunter D (2006) Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 42:843-852
36. Wainberg MA (2004) HIV-1 subtype distribution and the problem of drug resistance. AIDS 18(Suppl 3):S63-68
37. Wright E, Brew B, Lal L, Imran D, Lun W, Kamarulzaman A, Lim M, Robertson K, McArthur J, Wesselingh S, the APNAC Study Protocol Team (2006) Neurocognitive impairment, symptomatic peripheral neuropathy, and depression in HIV-infected outpatients within the Asia Pacific Region: Findings of the APNAC Study. In: 13th conference on retroviruses and opportunistic infections. Denver, CO, USA
38. Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate DF, Solomon S, Flanigan T (2006) Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc 12:424-430